Larry Altstiel
Hoofd Techniek/Wetenschap/O&O bij PROMIS NEUROSCIENCES, INC.
Vermogen: - $ op 30-04-2024
Profiel
Larry Douglas Altstiel was the founder of Provectra Therapeutics, Inc. founded in 2013, where he held the title of Chief Executive Officer from 2013 to 2015.
He is currently the Chief Medical Officer at Pinteon Therapeutics, Inc. and ProMIS Neurosciences, Inc. where he holds the title of Chief Medical Officer since 2022.
Dr. Altstiel's former jobs include Director at Neurotrope, Inc. from 2014 to 2016, Vice President-Neuroscience Clinical Development at Pfizer Inc. in 2013, Vice President-Research Operations at Eisai Medical Research, Inc., Senior VP & Head-Global Clinical Development at UCB Biosciences, Inc., Vice President-Research Operations at Schering Plough, Inc., and Chief Medical Officer & Executive Vice President at vTv Therapeutics, Inc. from 2015 to 2018.
Dr. Altstiel's education includes an undergraduate degree from the University of Illinois, a doctorate from The Rockefeller University, and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 26-10-2023 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Larry Altstiel
| Bedrijven | Functie | Begin |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 19-04-2022 |
Pinteon Therapeutics, Inc.
 Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Larry Altstiel
| Bedrijven | Functie | Einde |
|---|---|---|
| VTV THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 30-04-2018 |
| NEUROTROPE, INC. | Directeur/Bestuurslid | 11-02-2016 |
Provectra Therapeutics, Inc.
 Provectra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provectra Therapeutics, Inc. manufactures pharmaceutical products. The private company is based in Chapel Hill, NC. The company was founded by Larry Douglas Altstiel. | Algemeen Directeur | 01-12-2015 |
| PFIZER, INC. | Corporate Officer/Principal | 01-01-2013 |
| Schering Plough, Inc. | Corporate Officer/Principal | - |
Opleiding van Larry Altstiel
| The Rockefeller University | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| VTV THERAPEUTICS INC. | Health Technology |
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
Provectra Therapeutics, Inc.
Provectra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provectra Therapeutics, Inc. manufactures pharmaceutical products. The private company is based in Chapel Hill, NC. The company was founded by Larry Douglas Altstiel. | Health Technology |
| UCB BioSciences, Inc. | |
| Eisai Medical Research, Inc. | |
| Schering Plough, Inc. | |
Pinteon Therapeutics, Inc.
Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Health Technology |
